Management of Adult Patients with Acute Respiratory Distress Syndrome

Publication Date: November 29, 2023

Key Points

Key Points

  • The acute respiratory distress syndrome (ARDS) is a life-threatening form of respiratory failure characterized by acute hypoxemia and bilateral radiographic infiltrates.
  • ARDS management remains largely supportive, high mortality rates persist, with those who survive often facing long-term impairments.
  • Since 2017, new data have emerged addressing multiple ARDS therapies and supportive care interventions that include corticosteroids, venovenous extracorporeal membrane oxygenation (VV-ECMO) neuromuscular blocking agents (NMBAs), and positive end expiratory pressure (PEEP), prompting an update to the guidelines.
  • This guideline updates and adds to recommendations for the management of patients with ARDS (Figure 1).

Treatment

...atment...

...commendations in This Guideline...

We suggest using corticosteroids for patients wi...

...est using venovenous extracorporeal mem...

...suggest using neuromuscular blockers in...

...e suggest using higher PEEP without l...

...e recommend against using prolonged lung...


...ecommendations From the 2017 Guideline That Rema...

...recommend using mechanical ventilation s...

...prone positioning for >12 hours pe...

...commend against the routine use of high-freq...


...rent ATS Guidelines for the Management...


...autions and Practical Considerations f...